News and updates
October 13, 2023
Interview with Chris Bardon – GBR’s USA Life Sciences 2023 Report
October 10, 2023
AstronauTx closes £48 million ($61 million) Series A financing to create new treatments for Alzheimer’s disease
September 21, 2023
The Endpoints 11: The biotech startups making the biggest bets with the most exciting science in 2023
September 19, 2023
ReCode Therapeutics Announces Closing of Extension to Series B Financing
August 2, 2023
Reunion Neuroscience Inc. and MPM BioImpact Announce Completion of Plan of Arrangement
May 11, 2023
Chris Bardon of MPM Capital on CNBC’s “The Exchange”
April 27, 2023
Antiva Biosciences Closes $53 Million Series E Equity Financing Led by MPM-BioImpact Capital
January 10, 2023
NextPoint Therapeutics Announces $80 Million Series B Financing co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs
December 8, 2022
Ansbert Gadicke- Discusses the role of Innovation in Biotech
August 25, 2022
Aktis Oncology Raises $84 Million To Advance Novel Targeted Alpha Radiopharmaceuticals
August 16, 2022
Orna Therapeutics: circular logic
August 16, 2022
BioImpact Capital, an MPM affiliate, Announces a Multi-Billion Dollar Landmark Transaction in Vaccines and Cancer
August 16, 2022
Merck and Orna Therapeutics Collaborate to Advance Orna’s Next Generation of RNA Technology
August 16, 2022
Orna Therapeutics Raises $221 Million Series B Financing to Advance Circular RNA Platform and Accelerate Programs to the Clinic
June 2, 2022
Chris Bardon Interview (GBR Capital)
October 13, 2023
Interview with Chris Bardon – GBR’s USA Life Sciences 2023 Report
May 11, 2023
Chris Bardon of MPM Capital on CNBC’s “The Exchange”